Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in East Asians with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Lidan YangLin ZhangHe HeMei ZhangZhen-Mei AnPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2019)
Current research suggests that SGLT2 inhibitors have favorable efficacy and safety in East Asian patients with T2DM.